Diagnostic criteria of cancer cachexia: Relation to quality of life, exercise capacity and survival in unselected palliative care patients

Supportive Care in Cancer

Volumn 21, Issue 6, 2013, Pages 1569-1577

  Wallengren, Ola ^a   Lundholm, Kent ^a   Bosaeus, Ingvar ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cachexia classification; Cancer cachexia; Fatigue; Quality of life; Systemic inflammation; Weight loss

Indexed keywords

C REACTIVE PROTEIN; SERUM ALBUMIN;

ADVANCED CANCER; ADVERSE OUTCOME; AGED; ALBUMIN BLOOD LEVEL; ANEMIA; ARM CIRCUMFERENCE; ARTICLE; BODY MASS; CACHEXIA; CANCER PALLIATIVE THERAPY; ERYTHROCYTE SEDIMENTATION RATE; EXERCISE; FATIGUE; FEMALE; FUNCTIONAL STATUS; GRIP STRENGTH; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; PHYSICAL CAPACITY; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL TIME; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; CACHEXIA; EXERCISE TOLERANCE; FATIGUE; FEMALE; GASTROINTESTINAL NEOPLASMS; HAND STRENGTH; HUMANS; INFLAMMATION; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; NEOPLASMS; PALLIATIVE CARE; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; WEIGHT LOSS;

EID: 84879155722     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1697-z     Document Type: Article

References (32)

1. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489-495. doi: 10.1016/S1470-2045(10)70218-7
2. Blum D, Omlin A, Baracos VE, Solheim TS, Tan BH, Stone P, Kaasa S, Fearon K, Strasser F (2011) Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol. doi: 10.1016/j.critrevonc.2010.10.004
3. Tisdale MJ (2010) Cancer cachexia. Curr Opin Gastroenterol 26(2):146-151. doi: 10.1097/MOG.0b013e3283347e77
4. Bozzetti F, Mariani L (2009) Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group. J Parenter Enter Nutr 33(4):361-367. doi: 10.1177/0148607108325076
5. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD (2008) Cachexia: a new definition. Clin Nutr 27(6):793-799. doi: 10.1016/j.clnu.2008.06.013
6. Fearon KC, Voss AC, Hustead DS (2006) Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83(6):1345-1350
7. Macdonald N (2012) Terminology in cancer cachexia: importance and status. Curr Opin Clin Nutr Metab Care 15(3):220-225. doi: 10.1097/MCO.0b013e328352a895
8. Baldwin C, Spiro A, Ahern R, Emery PW (2012) Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. J Natl Cancer Inst 104(5):371-385. doi: 10.1093/jnci/djr556
9. Elia M, Bokhorst-de V, van der Schueren MA, Garvey J, Goedhart A, Lundholm K, Nitenberg G, Stratton RJ (2006) Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol 28(1):5-23
10. Lundholm K, Daneryd P, Bosaeus I, Korner U, Lindholm E (2004) Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function. Cancer 100(9):1967-1977
11. Mantovani G, Maccio A, Madeddu C, Serpe R, Massa E, Dessi M, Panzone F, Contu P (2010) Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia. Oncologist 15(2):200-211. doi: 10.1634/theoncologist.2009-0153
12. Mantovani G, Maccio A, Madeddu C, Serpe R, Antoni G, Massa E, Dessi M, Panzone F (2010) Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia. J Mol Med (Berl) 88(1):85-92. doi: 10.1007/s00109-009-0547-z
13. Fearon KC (2008) Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer 44(8):1124-1132. doi: 10.1016/j.ejca.2008.02.033
14. Fearon KC, Barber MD, Moses AG, Ahmedzai SH, Taylor GS, Tisdale MJ, Murray GD (2006) Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol 24(21):3401-3407. doi: 10.1200/JCO.2005.04.5724
15. Fox KM, Brooks JM, Gandra SR, Markus R, Chiou CF (2009) Estimation of cachexia among cancer patients based on four definitions. J Oncol 2009:693458. doi: 10.1155/2009/693458
16. Thoresen L, Frykholm G, Lydersen S, Ulveland H, Baracos V, Prado CM, Birdsell L, Falkmer U (2012) Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results. Clin Nutr. doi: 10.1016/j.clnu.2012. 05.009
17. Lundholm K, Daneryd P, Korner U, Hyltander A, Bosaeus I (2004) Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia. Int J Oncol 24(3):505-512
18. Daneryd P, Svanberg E, Korner U, Lindholm E, Sandstrom R, Brevinge H, Pettersson C, Bosaeus I, Lundholm K (1998) Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study. Cancer Res 58(23):5374-5379
19. Lindholm E, Daneryd P, Korner U, Hyltander A, Fouladiun M, Lundholm K (2004) Effects of recombinant erythropoietin in palliative treatment of unselected cancer patients. Clin Cancer Res 10(20):6855-6864. doi: 10.1158/1078-0432.CCR-04-0373
20. Lundholm K, Korner U, Gunnebo L, Sixt-Ammilon P, Fouladiun M, Daneryd P, Bosaeus I (2007) Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning. Clin Cancer Res 13(9):2699-2706. doi: 10.1158/1078-0432.CCR-06-2720
21. Symreng T (1982) Arm anthropometry in a large reference population and in surgical patients. Clin Nutr 1(3):211-219
22. Persson H, Bennegard K, Lundberg PA, Svaninger G, Lundholm K (1985) Thyroid hormones in conditions of chronic malnutrition. A study with special reference to cancer cachexia. Ann Surg 201(1):45-52
23. Håglin L, Hagman U, Nilsson M (1995) Evaluation of the meal model «Matmallen». A means of estimating consumed amounts of food. Scandinavian Journal of Nutrition 39:79-83
24. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365-376
25. Scott NW FP, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MAG on behalf of the EORTC Quality of Life Group (2008) EORTC QLQ-C30 reference values. http://groups.eortc.be/qol/sites/ default/files/img/newsletter/reference-values-manual2008.pdf
26. Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139-144
27. Quinten C, Coens C, Mauer M, Comte S, Sprangers MA, Cleeland C, Osoba D, Bjordal K, Bottomley A (2009) Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 10(9):865-871. doi: 10.1016/S1470-2045(09)70200-1
28. Trajkovic-Vidakovic M, de Graeff A, Voest EE, Teunissen SCCM (2012) Symptoms tell it all: a systematic review of the value of symptom assessment to predict survival in advanced cancer patients. Critical Reviews in Oncology/Hematology (0)
29. Marin Caro MM, Laviano A, Pichard C (2007) Nutritional intervention and quality of life in adult oncology patients. Clin Nutr 26(3):289-301
30. Wanden-Berghe C, Sanz-Valero J, Escriba-Aguir V, Castello-Botia I, Guardiola-Wanden-Berghe R (2009) Evaluation of quality of life related to nutritional status. Br J Nutr 101(7):950-960. doi: 10.1017/S0007114508207178
31. Wallengren O, Bosaeus I, Lundholm K (2012) Dietary energy density, inflammation and energy balance in palliative care cancer patients. Clin Nutr. doi: 10.1016/j.clnu.2012.05.023
32. Vigano A, Del Fabbro E, Bruera E, Borod M (2012) The cachexia clinic: from staging to managing nutritional and functional problems in advanced cancer patients. Crit Rev Oncog 17(3):293-304